Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Musset

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|January 1, 1997
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapyE Brain, C Garrino, J L Misset, et al.
La Nouvelle Presse Medicale|December 20, 1975
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]J L Misset, P Pouillart, J L Amiel, et al.
Cancer|October 1, 1974
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasG Mathé, L Schwarzenberg, P Pouillart, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|May 1, 1976
[Possibilities and indications of surgery for reduction of tumor volume or exeresis of metastases followed by chemotherapy and/or immunotherapy]G Mathe, H Garnier, R Kuss, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Immunoblastic lymphosarcoma, a cytological and clinical entity?G Mathé, D Belpomme, D Dantchev, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumoursG Mathé, B Serrou, M Hayat, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1974
Immunoblastic acute lymphoid leukaemiaG Mathé, D Belpomme, D Dantchev, et al.
La Nouvelle Presse Medicale|February 18, 1978
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]G Marthé, J L Misset, F de Vassal, et al.
Cancer Treatment Reports|May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristineG Mathé, J L Misset, F De Vassal, et al.
La Nouvelle Presse Medicale|May 3, 1975
[Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]G Mathé, J L Amiel, L Schwarzenberg, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|January 1, 1997
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapyE Brain, C Garrino, J L Misset, et al.
La Nouvelle Presse Medicale|December 20, 1975
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]J L Misset, P Pouillart, J L Amiel, et al.
Cancer|October 1, 1974
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasG Mathé, L Schwarzenberg, P Pouillart, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|May 1, 1976
[Possibilities and indications of surgery for reduction of tumor volume or exeresis of metastases followed by chemotherapy and/or immunotherapy]G Mathe, H Garnier, R Kuss, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Immunoblastic lymphosarcoma, a cytological and clinical entity?G Mathé, D Belpomme, D Dantchev, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumoursG Mathé, B Serrou, M Hayat, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1974
Immunoblastic acute lymphoid leukaemiaG Mathé, D Belpomme, D Dantchev, et al.
La Nouvelle Presse Medicale|February 18, 1978
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]G Marthé, J L Misset, F de Vassal, et al.
Cancer Treatment Reports|May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristineG Mathé, J L Misset, F De Vassal, et al.
La Nouvelle Presse Medicale|May 3, 1975
[Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]G Mathé, J L Amiel, L Schwarzenberg, et al.
Pageof 6